logologo
Search stocks, ETFs, IPOs & more
Quest
arrow
WhatsApp Icon

NSE IPO: Expected Price, Listing Premium, Valuation

Talk around the upcoming National Stock Exchange (NSE) IPO has intensified across Reddit, LinkedIn, and market forums, largely because the official price band is still not out. In the absence of the RHP, investors are triangulating from unlisted share prices, issue-size headlines, and valuation comparisons with listed peers.

The most repeated point across social posts is simple: NSE has filed its draft papers, but the IPO pricing is still unofficial. Several discussions highlight that the IPO price band will be disclosed in the RHP closer to the subscription window. This has led to multiple “expected price” ranges circulating at the same time, sometimes contradicting each other. A second big theme is the gap between unlisted market pricing and what investors think the IPO might be priced at. On Reddit and similar forums, that gap is being framed as either a potential listing-day “discount” for new investors or a risk that unlisted buyers have already paid up. Another frequent thread is the size of the IPO, with estimates clustering around a very large fund raise and a relatively small dilution figure. Many posts also focus on who benefits from stake sales, especially long-time institutional holders. The final theme is long-term potential, with some users calling it a “financial infrastructure” compounding story if participation in capital markets keeps rising.

Where NSE unlisted shares are trading

Posts repeatedly cite NSE’s unlisted share price around ₹1,950 to ₹2,055 per share, with some references around ₹2,075 and ₹1,975. One widely shared datapoint claims the stock moved up nearly 10 percent to ₹2,000 to ₹2,050 from roughly ₹1,850 just days earlier. Another detailed social post anchors on ₹1,975 per share and notes 247.5 crore shares outstanding, implying a market capitalisation of about ₹4,88,813 crore. That same post cites FY26 annualised PAT of ₹9,758 crore and calculates a P/E of 50.1x at that unlisted price. Separately, a LinkedIn post mentions a “current P/E” of about 50x and an “expected IPO P/E” of about 40x, positioning it as a potential reset versus private-market pricing. Across platforms, the unlisted price is being treated as the most immediate reference point, even though it can be driven by liquidity, transaction friction, and investor positioning ahead of the IPO.

Expected NSE IPO price band: why estimates vary

Reddit-style analysis threads stress that the price band is not yet officially announced and will come with the RHP. One model-driven view circulating online suggests a fair value price band of ₹1,258 to ₹1,867, with a blended fair value around ₹1,565 after combining DCF, “exchange premium”, peer multiples, and recent market deals. In parallel, a LinkedIn post discussing the DRHP suggests an expected IPO price of ₹1,400 to ₹1,600, while also floating a different band of ₹1,800 to ₹2,100 in the same broader discussion stream. Another set of commentary links the potential offer size of roughly ₹28,000 to ₹32,000 crore to a possible price band around ₹1,900 to ₹2,000 per share. Reuters-sourced discussion adds a different framing: merchant banker sources indicating shares might be offered at a 5 percent to 10 percent discount to private market valuations, with a discussed valuation around ₹1,900 per share. Put together, the “expected” price band debate is less about one number and more about which anchor investors trust most: model-based fair value, the unlisted tape, or issue-structure math.

Source or discussion threadPrice or band citedAdditional context cited in the same thread
Model-based social analysis₹1,258 to ₹1,867Blends DCF, exchange premium, peer multiples, market deals; blended fair value cited near ₹1,565
LinkedIn post on DRHP chatter₹1,400 to ₹1,600Also mentions expected IPO P/E ~40x; unlisted price cited near ₹2,075
Issue-size based estimate₹1,900 to ₹2,000Uses issue size ₹28,000 to ₹32,000 crore as a reference
Reuters-sourced market talkAround ₹1,900Mentions 5 percent to 10 percent discount to private-market valuations

Valuation range being debated: ₹4.8-5 lakh crore to ₹6-7 trillion

Much of the social conversation is anchored to a valuation of roughly ₹4.8 to ₹5 lakh crore, which is repeatedly linked to unlisted trading levels and to proposed offer sizing. One Reuters-style snippet frames the IPO as potentially raising about $1.3 billion and valuing NSE around $17 billion, alongside the point that existing shareholders could sell about 6 percent of their stakes. Another widely shared estimate suggests a valuation of ₹4.8 to ₹5 lakh crore, consistent with unlisted trading references near ₹1,900 to ₹2,000. A separate report discussed on social media says NSE could target a higher valuation of ₹6 trillion to ₹7 trillion, and that at this range the issue size could be ₹28,000 crore to ₹38,000 crore. That same report notes that if NSE seeks a valuation near ₹7 trillion, it could represent a premium of roughly 40 percent over its current valuation of about ₹5 trillion in the unlisted market. Users also debate valuation through earnings multiples, with one discussion suggesting a ₹5 lakh crore market cap could imply about 36x FY28 EPS and a 10 percent to 15 percent discount to BSE valuations. Another clip argues that an exchange with sustainable EBITDA margins of over 70 percent can command such multiples, though the posts do not provide the full financial statements to validate every assumption.

Listing price versus unlisted price: discount, parity, or premium

A central question in the threads is whether the IPO will be priced below, near, or above the unlisted market. Reuters-cited sources mention the exchange might offer shares at a 5 percent to 10 percent discount compared to private market valuations to attract new investors while not disadvantaging existing holders. That sits alongside the view that the IPO price could “align closely with current valuations”, with one CEO quoted in social chatter suggesting an issue price near ₹2,000 in a scenario shaped by dilution norms for very large companies. On the other side, a Mumbai boutique market participant is quoted as saying NSE appears overvalued above ₹2,000 and suggests a more reasonable range of ₹1,500 to ₹1,800. The model-driven fair-value band of ₹1,258 to ₹1,867 fits more closely with the “discount to unlisted” camp. The competing implication is straightforward: if the IPO prices materially below unlisted deals, unlisted buyers risk mark-to-market pain, but new IPO buyers could see a better entry. If the IPO prices at or above the unlisted tape, the near-term “listing pop” thesis becomes harder to justify, but long-term holders may still focus on fundamentals and market structure.

Timeline and process: DRHP filed, SEBI review, roadshows

Several posts agree on the key procedural milestone: NSE filed its DRHP with SEBI on June 18, 2026. Social summaries say SEBI is currently reviewing the draft papers and that the process could take around 2 to 3 months. Based on that timeline, the IPO is expected by some commentators to launch around September to October 2026, with listing likely before December 2026, subject to approvals and market conditions. Another discussion references management commentary pointing to a targeted listing by end-2026, again conditional. Reuters-style reporting also mentions investor roadshows, with the final pricing decision expected closer to the listing date after these meetings. Posts add that both local mutual funds and international investors have shown preliminary interest, although no allocations or anchors are confirmed in the provided material. The recurring takeaway is that pricing clarity is likely to arrive late in the process, and that roadshow feedback can materially influence where the final band lands versus unlisted prices.

Offer structure and shareholder selling: who could benefit

Across social media, the offer is repeatedly described as being driven by existing shareholder sales rather than a large fresh issuance, with one line stating shareholders could sell around 6 percent of their stakes. Multiple threads highlight that long-term holders, particularly institutions that acquired shares very early, could see large gains if they sell into the IPO. One Business Today-linked discussion mentions insurance giants such as New India Assurance and National Insurance Company as potential big beneficiaries, alongside banks such as State Bank of India and Bank of Baroda. A quoted estimate suggests New India Assurance and National Insurance could earn up to roughly 6,400 times their original investment, with another example citing United Insurance with a lower but still very large multiple based on a much lower acquisition cost. Reuters-style calculations referenced in the context also point to meaningful profits for top investors in the share sale, naming SBI, Temasek, and Canada Pension Plan Investment Board among those expected to benefit. These figures are being used in social posts to illustrate how long the pre-IPO shareholder base has waited for liquidity. For new investors, the relevance is indirect but important: heavy profit-taking by early holders can shape headline supply dynamics and sentiment around pricing.

Long-term potential cited: cash market dominance and market deepening

Long-term posts tend to focus less on listing-day gains and more on what drives exchange earnings over years. Reuters-context commentary says growth depends on the ongoing influx of first-time investors, increased trading activity, innovation in derivatives products, and expansion into commodities. A former group president at NSE, now a consultant, is quoted highlighting NSE’s dominant position in the cash market and arguing that as India’s market capitalisation expands, cash trading volumes are expected to steadily increase. Another social post frames NSE as India’s largest and most profitable exchange and notes that it operates the globally tracked Nifty 50 index, positioning it as an asset that global funds can buy only after listing. Some discussions explicitly connect a listing to broadened ownership, suggesting foreign institutional investors, index funds, and global long-only funds cannot hold unlisted paper today. There is also a recurring argument that the business commands an “exchange premium” that simple DCF models can miss, hence the push for blended valuation methods. At the same time, posts caution that buying near unlisted levels may already embed an “option premium” for the listing catalyst, meaning long-term returns would depend on sustained earnings growth rather than a one-time re-rating.

Key uncertainties investors are flagging before subscribing

The most obvious uncertainty is that the price band is not official yet, and several ranges being shared cannot all be right at the same time. Another uncertainty is the eventual valuation target, with social chatter spanning roughly ₹5 trillion and ₹6 trillion to ₹7 trillion, which would materially change perceived upside or downside from unlisted prices. Timing is also not locked, even if many posts cluster around late-2026, because approvals and market conditions can shift the schedule. A related risk is the gap between private-market liquidity and listed-market price discovery, especially if the IPO is priced at a discount to unlisted deals. Some commentators also flag valuation comfort, with one saying NSE looks overvalued above ₹2,000, while others argue that high margins and durable market position justify higher multiples. Investors in the discussion frequently recommend waiting for the RHP to confirm price band and valuation approach before making hard conclusions. For long-term holders, the debate is less about the exact listing price and more about whether India’s capital market participation and product expansion keep compounding over the next few years.

Frequently Asked Questions

No. Social posts note the price band is expected to be disclosed in the RHP closer to the subscription window.
Different posts cite ₹1,258-₹1,867 (model-based fair value), ₹1,400-₹1,600 (LinkedIn estimate), and ₹1,900-₹2,000 (issue-size and unlisted-linked estimates).
The context cites unlisted trades around ₹1,950-₹2,055 per share, with specific mentions near ₹1,975 and ₹2,075.
Posts say NSE filed the DRHP on June 18, 2026, with SEBI review estimated at 2-3 months, and some expect an IPO around September-October 2026 and listing before December 2026, subject to approvals.
Reuters-sourced commentary mentions the exchange might offer shares at a 5%-10% discount to private market valuations to attract new investors while aiming not to disadvantage existing holders.

Did your stocks survive the war?

See what broke. See what stood.

Live Q1 Earnings Tracker